Several other brokerages have also commented on SPH. Jefferies Group dropped their price objective on Sinclair Pharma PLC from GBX 60 ($0.78) to GBX 55 ($0.72) and set a buy rating on the stock in a report on Wednesday, June 15th. Peel Hunt lifted their price target on Sinclair Pharma PLC from GBX 66 ($0.86) to GBX 68 ($0.89) and gave the stock a buy rating in a research note on Thursday, September 1st. Stifel Nicolaus reaffirmed a buy rating and issued a GBX 49 ($0.64) price target on shares of Sinclair Pharma PLC in a research note on Thursday, September 1st. Finally, Royal Bank Of Canada reaffirmed an outperform rating on shares of Sinclair Pharma PLC in a research note on Thursday, September 15th. Five investment analysts have rated the stock with a buy rating, Sinclair Pharma PLC has an average rating of Buy and a consensus price target of GBX 57 ($0.74).
Sinclair Pharma PLC (LON:SPH) opened at 28.9424 on Wednesday. The firm has a 50-day moving average price of GBX 28.87 and a 200 day moving average price of GBX 31.96. The company’s market cap is GBX 143.84 million. Sinclair Pharma PLC has a 12 month low of GBX 26.00 and a 12 month high of GBX 61.33.
In related news, insider Jeff Thompson acquired 150,000 shares of Sinclair Pharma PLC stock in a transaction that occurred on Tuesday, October 4th. The shares were purchased at an average price of GBX 29 ($0.38) per share, for a total transaction of £43,500 ($56,781.10).
About Sinclair Pharma PLC
Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and Spain, and International Operations, under which the Company sells through a local distributor.
Receive News & Ratings for Sinclair Pharma PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinclair Pharma PLC and related companies with MarketBeat.com's FREE daily email newsletter.